Products
Online Inquiry
Lucidenic acid B
Cat. No.:
OB0626WX-112
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Lucidenic acid B is a highly oxygenated triterpenoid isolated from Ganoderma lucidum that possesses significant anti-neoplastic and cytostatic properties, demonstrating targeted inhibition of phorbol 12-myristate 13-acetate-induced Epstein-Barr virus early antigen production within Raji Burkitt lymphoma models.
Synonyms:
(5α,7β,12β)-7,12-dihydroxy-4,4,14-trimethyl-3,11,15-trioxo-chol-8-en-24-oic acid; Lucidenic Acid D2; 95311-95-8; (4R)-4-[(5R,7S,10S,12S,13R,14R,17R)-7,12-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid; LucidenicacidB; (+)-Lucidenic Acid B; 7beta,12beta-Dihydroxy-4,4,14-trimethyl-3,11,15-trioxo-5alpha-chol-8-en-24-oic acid; (5alpha,7beta,12beta)-7,12-Dihydroxy-4,4,14-trimethyl-3,11,15-trioxo-chol-8-en-24-oic acid
CAS No.:
95311-95-8
Compound CID:
102410351
Formula:
C27H38O7
Formula Weight:
474.6
Specification
Source:
Ganoderma sp.
Solubility in Other Solvents:
Methanol: 0.1-1 mg/mL
Storage:
Storage at -20°C.
Applications:
Lucidenic acid B serves as a triterpenoid natural product reference compound for analytical characterization and investigation of fungal-derived metabolites. It supports chromatographic profiling, structural identification, and comparative analysis of specialized secondary metabolites.